HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The efficacy of exogenous and endogenous interferonization in preventing influenza].

Abstract
In this work the results of using interferon (IFN), Dibasol and the combination of these preparations for the urgent prophylaxis of influenza and acute respiratory diseases (ARD) among the employees of the Gamaleia Research Institute of Epidemiology and Microbiology (USSR Acad. Med. Sci.) are summarized. Reaferon and Dibasol decrease ARD morbidity 2 times and leukocytic IFN decreases it 1.4 times, while the combined administration of Dibasol and IFN has proved to be ineffective. Reaferon is mainly a prophylactic remedy; it has been found to bring about almost no decrease in the number of patients at the peak of morbidity, while pronouncedly decreasing it in two weeks after the administration of the preparation. Dibasol has a curative effect, sharply interrupting the beginning rise of morbidity. Reaferon normalizes the characteristics of the IFN status, decreasing the amount of circulating IFN and enhancing the capacity of leukocytes for producing alpha-IFN and gamma-IFN. For the prophylaxis of respiratory infections the use of Reaferon is advisable 3-4 weeks prior to the beginning of the epidemic and then, when the first cases of infection are registered, the course of prophylaxis with Dibasol should be carried out.
AuthorsF I Ershov, S S Grigorian, T A Semenenko, V V Malinovskaia, O A Tarasenko, V I Agafonov, S V Prozorovskiĭ
JournalZhurnal mikrobiologii, epidemiologii i immunobiologii (Zh Mikrobiol Epidemiol Immunobiol) Issue 10 Pg. 42-5 (Oct 1991) ISSN: 0372-9311 [Print] Russia (Federation)
Vernacular TitleEffektivnost' ékzogennoĭ i éndogennoĭ interferonizatsii pri profilaktike grippa.
PMID1724860 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Benzimidazoles
  • Interferon Inducers
  • Interferon Type I
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • bendazole
  • Interferons
Topics
  • Absenteeism
  • Benzimidazoles (therapeutic use)
  • Drug Evaluation
  • Drug Therapy, Combination
  • Humans
  • Influenza, Human (blood, epidemiology, prevention & control)
  • Interferon Inducers (therapeutic use)
  • Interferon Type I (therapeutic use)
  • Interferon alpha-2
  • Interferon-alpha (therapeutic use)
  • Interferons (blood)
  • Middle Aged
  • Moscow (epidemiology)
  • Recombinant Proteins
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: